HISAMITSU PHARMACEUTICAL CO.,INC. [4530.T]
TOKYO, May 08 (Pulse News Wire) – Hisamitsu Pharmaceutical Co.,inc. (4530.T) announced today that its ordinary shares will be delisted effective May 11, 2026, following approval of a share consolidation proposal at the extraordinary shareholders' meeting held on April 17, 2026.
The decision was made due to the company's stock meeting the delisting criteria set by the Tokyo Stock Exchange, Nagoya Stock Exchange, and Fukuoka Securities Association. Details of the share consolidation and related changes can be found in the press release dated April 17, 2026, titled “Approval of Share Consolidation, Abolition of Unit Share Number Determination, and Partial Amendment of Articles of Incorporation.” “We would like to express our sincere gratitude to our shareholders and stakeholders for their long-standing support and understanding,” said K Kazuhiro Nakafuchi, President and CEO of Hisamitsu Pharmaceutical.
“We remain committed to enhancing our corporate value going forward.”.
🟢 Confidence: High AI-translated content.